Association Between Common Variants in <i>RBFOX1</i>, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease

Neha Raghavan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Susan M. Resnick(National Institute on Aging), Timothy J. Hohman(Vanderbilt University Medical Center), David A. Bennett(Rush University Medical Center), Emily R. Mahoney(Vanderbilt University Medical Center), Julie A. Schneider(University of California San Diego), David B. Goldstein(Electronic BioSciences (United States)), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative), Logan Dumitrescu(Vanderbilt University Medical Center), Corinne D. Engelman(University of Wisconsin–Madison), Philip L. De Jager(Broad Institute), Hyun‐Sik Yang(Broad Institute), William J. Jagust(Lawrence Berkeley National Laboratory), Yizhe Gao(Columbia University Irving Medical Center), Christopher D. Whelan(Biogen (United States)), Annie Lee(Columbia University Irving Medical Center), Richard Mayeux(Columbia University), Elizabeth C. Mormino(Allen Institute for Brain Science), Theresa M. Harrison(University of California, Berkeley), Matthew Schrag(Vanderbilt University), Sterling C. Johnson(Wisconsin Society for Cardiovascular and Pulmonary Health & Rehabilitation), Murat Bilgel(Institute on Aging), Keith A. Johnson(Brigham and Women's Hospital), Badri N. Vardarajan(Columbia College), Jimmy Z. Liu(QIMR Berghofer Medical Research Institute), Paul Aisen(University of Southern California), Reisa A. Sperling(Harvard University), Marilyn Albert(Johns Hopkins Medicine)
JAMA Neurology
June 22, 2020
Cited by 101


Related Papers